A discrete choice experiment to assess treatment preferences for patients with esophageal cancer in Japan
We first clarified patients' preferences for EC systemic therapy in Japan, which could provide useful information in EC treatment selection.
Authors
- H Matsumoto
- Yasuo Hamamoto (ORCID: https://orcid.org/0000-0002-5737-122X)
- Tsunehisa Yamamoto (ORCID: https://orcid.org/0000-0002-5241-9482)
- Hiroaki Ito (ORCID: https://orcid.org/0000-0001-8503-141X)
- Akihiko Inagawa
Institutions
- Tokyo Medical and Dental University (JP)
- Keio University (JP)
- Ono Pharmaceutical (Japan) (JP)
- Bristol-Myers Squibb (Japan) (JP)
Publication Details
- Journal
- Esophagus
- Published
- 2025-07-21
- DOI
- https://doi.org/10.1007/s10388-025-01143-6
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- Ono Pharmaceutical